VitalFlo, founded with a mission to revolutionize asthma management, is a digital health company that offers remote monitoring devices and predictive analytics to help doctors keep their asthmatic patients out of the ER. By tracking patient lung function and local air quality, VitalFlo provides actionable recommendations to prevent asthma attacks. The company aims to redefine the standard of care for asthma by offering real-time data and insights, primarily targeting hospitals, health systems, physician groups, and clinical trials.
Notable affiliated people and investors include key figures in healthcare technology and venture capital, although specific names are not publicly disclosed. VitalFlo has achieved significant milestones in improving patient outcomes through its proactive respiratory care platform. Its impact is evident in the enhanced connection between patients and providers, leading to better management of chronic respiratory conditions and reduced emergency room visits.
